Assessment of tDCS-Induced Neuronal Responses in Multiple Sclerosis (MS) With Advanced MRI



Status:Recruiting
Conditions:Neurology, Neurology, Multiple Sclerosis
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:18 - 79
Updated:10/7/2018
Start Date:July 9, 2018
End Date:June 2020
Contact:Kai Sherman
Email:Kai.Sherman@nyumc.org
Phone:929 455 5125

Use our guide to learn which trials are right for you!

The objective of this trial is to measure the changes in neural activities during tDCS
session using Magnetic Resonance Imaging (MRI). Participants (N=60) (20 Healthy Controls and
40 participants with neurological disorders, ie. multiple sclerosis) will be recruited to
complete self-report measures and a brief cognitive assessment and then undergo an hour long
stand-alone MRI scan while simultaneously undergoing tDCS stimulation. Methodology for this
study is the administration of 15-minutes of of active tDCS during MRI acquisition compared
to time without active tDCS.


Inclusion Criteria:

- Standardized SDMT Z-scores ≥3 standard deviations below mean

- Able to understand all study instructions and supply written consent

Exclusion Criteria:

- Extreme claustrophobia

- History of mental retardation, pervasive developmental disorder or other neurological
condition associated with cognitive impairment

- Primary psychiatric disorder that would influence ability to participate

- History of seizures or seizure disorder

- History of head trauma in the past year (e.g., head injury, brain surgery) or medical
device implanted in the head (such as Deep Brain Stimulator) or in the neck (such as a
Vagus Nerve Stimulator)

- Any skin disorder/sensitive skin (e.g., eczema, severe rashes), blisters, open wounds,
burn including sunburns, cuts or irritation, or other skin defects which compromise
the integrity of the skin at or near stimulation locations (where electrodes are
placed)

- Treatment for a communicable skin disorder currently or over the past 12 months

- History of uncontrolled or labile hypertension.

- Have any irremovable piercings, implantations or metallic-based tattoos

- History of clinically significant abnormalities on electrocardiogram (EKG)

- Pregnant or breastfeeding

- Current substance abuse disorder
We found this trial at
1
site
550 1st Ave
New York, New York 10016
(212) 263-7300
Principal Investigator: Leigh Charvet, MD
Phone: 929-455-5125
New York University School of Medicine NYU School of Medicine has a proud history that...
?
mi
from
New York, NY
Click here to add this to my saved trials